DOP2013000099A - COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3 - Google Patents
COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3Info
- Publication number
- DOP2013000099A DOP2013000099A DO2013000099A DO2013000099A DOP2013000099A DO P2013000099 A DOP2013000099 A DO P2013000099A DO 2013000099 A DO2013000099 A DO 2013000099A DO 2013000099 A DO2013000099 A DO 2013000099A DO P2013000099 A DOP2013000099 A DO P2013000099A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- phenylsulphanylme
- mglur
- antagonists
- hexane
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a un antagonista del receptor mGlu2/3 de la fórmula: se describen sus usos, y métodos para su preparación.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41512110P | 2010-11-18 | 2010-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2013000099A true DOP2013000099A (es) | 2013-08-15 |
Family
ID=45099188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2013000099A DOP2013000099A (es) | 2010-11-18 | 2013-05-08 | COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR 2/3 |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8629169B2 (es) |
| EP (1) | EP2640697B1 (es) |
| JP (1) | JP5877847B2 (es) |
| KR (2) | KR20150140876A (es) |
| CN (1) | CN103228625B (es) |
| AR (1) | AR083845A1 (es) |
| AU (1) | AU2011329076B2 (es) |
| BR (1) | BR112013012118A2 (es) |
| CA (1) | CA2818116C (es) |
| CL (1) | CL2013001345A1 (es) |
| CO (1) | CO6761385A2 (es) |
| CR (1) | CR20130178A (es) |
| DK (1) | DK2640697T3 (es) |
| DO (1) | DOP2013000099A (es) |
| EA (1) | EA021724B1 (es) |
| EC (1) | ECSP13012629A (es) |
| ES (1) | ES2650139T3 (es) |
| GT (1) | GT201300126A (es) |
| HR (1) | HRP20171649T1 (es) |
| HU (1) | HUE037457T2 (es) |
| IL (1) | IL225843A (es) |
| LT (1) | LT2640697T (es) |
| MA (1) | MA34663B1 (es) |
| MX (1) | MX339973B (es) |
| NO (1) | NO2640697T3 (es) |
| NZ (1) | NZ609816A (es) |
| PE (1) | PE20140997A1 (es) |
| PL (1) | PL2640697T3 (es) |
| PT (1) | PT2640697T (es) |
| RS (1) | RS56535B1 (es) |
| SG (1) | SG189959A1 (es) |
| SI (1) | SI2640697T1 (es) |
| TW (1) | TWI520935B (es) |
| UA (1) | UA110039C2 (es) |
| WO (1) | WO2012068067A1 (es) |
| ZA (1) | ZA201302918B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR079343A1 (es) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico |
| EP3000814A1 (en) | 2014-09-26 | 2016-03-30 | Domain Therapeutics | Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors |
| AU2017254266B2 (en) | 2016-04-18 | 2021-03-11 | Taisho Pharmaceutical Co., Ltd. | Prodrug of amino acid derivative |
| JP2020506895A (ja) | 2017-01-17 | 2020-03-05 | ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | インドールアミン２，３−ジオキシゲナーゼおよび／またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物 |
| US11046649B2 (en) | 2018-07-17 | 2021-06-29 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0669928B2 (ja) | 1987-10-06 | 1994-09-07 | 宇部興産株式会社 | 光重合性歯科材料 |
| JP2589812B2 (ja) | 1989-07-05 | 1997-03-12 | 松下電器産業株式会社 | スチームアイロン |
| ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
| WO1997017950A1 (en) | 1995-11-16 | 1997-05-22 | Eli Lilly And Company | Shoulder prosthesis |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| NZ506227A (en) * | 1998-03-17 | 2003-06-30 | Pfizer Prod Inc | Bicyclo[2.2.1]heptanes and their use in treating neurological and psychiatric disorders |
| GB9815542D0 (en) | 1998-07-17 | 1998-09-16 | Lilly Co Eli | Bicyclohexane derivatives |
| CH694053A5 (de) | 1998-09-03 | 2004-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten. |
| WO2002068380A1 (en) * | 2001-02-22 | 2002-09-06 | Eli Lilly And Company | Synthetic excitatory amino acids |
| EP1459765B1 (en) | 2001-12-27 | 2008-08-20 | Taisho Pharmaceutical Co., Ltd | 6-fluorobicyclo 3.1.0 hexane derivatives |
| EP1517915B1 (en) | 2002-06-11 | 2009-01-21 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| JP4984529B2 (ja) * | 2003-06-26 | 2012-07-25 | 大正製薬株式会社 | ２−アミノビシクロ［３．１．０］ヘキサン−２，６−ジカルボン酸誘導体 |
| JP4792971B2 (ja) * | 2003-06-26 | 2011-10-12 | 大正製薬株式会社 | ２−アミノ−ビシクロ［３．１．０］ヘキサン−２，６−ジカルボン酸エステル誘導体 |
| JP2007063129A (ja) | 2003-06-26 | 2007-03-15 | Taisho Pharmaceut Co Ltd | ２−アミノ−３−アルコキシビシクロ［３．１．０］ヘキサン誘導体 |
| AR079343A1 (es) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico |
-
2011
- 2011-11-11 TW TW100141326A patent/TWI520935B/zh not_active IP Right Cessation
- 2011-11-11 AR ARP110104219A patent/AR083845A1/es unknown
- 2011-11-15 PE PE2013001215A patent/PE20140997A1/es not_active Application Discontinuation
- 2011-11-15 PT PT117916924T patent/PT2640697T/pt unknown
- 2011-11-15 RS RS20171082A patent/RS56535B1/sr unknown
- 2011-11-15 ES ES11791692.4T patent/ES2650139T3/es active Active
- 2011-11-15 DK DK11791692.4T patent/DK2640697T3/en active
- 2011-11-15 LT LTEP11791692.4T patent/LT2640697T/lt unknown
- 2011-11-15 SG SG2013030507A patent/SG189959A1/en unknown
- 2011-11-15 UA UAA201305835A patent/UA110039C2/ru unknown
- 2011-11-15 PL PL11791692T patent/PL2640697T3/pl unknown
- 2011-11-15 CN CN201180055263.7A patent/CN103228625B/zh active Active
- 2011-11-15 NO NO11791692A patent/NO2640697T3/no unknown
- 2011-11-15 WO PCT/US2011/060730 patent/WO2012068067A1/en active Application Filing
- 2011-11-15 SI SI201131304T patent/SI2640697T1/sl unknown
- 2011-11-15 EA EA201390498A patent/EA021724B1/ru not_active IP Right Cessation
- 2011-11-15 KR KR1020157034547A patent/KR20150140876A/ko not_active Application Discontinuation
- 2011-11-15 BR BR112013012118A patent/BR112013012118A2/pt not_active IP Right Cessation
- 2011-11-15 CA CA2818116A patent/CA2818116C/en active Active
- 2011-11-15 HU HUE11791692A patent/HUE037457T2/hu unknown
- 2011-11-15 MX MX2013005622A patent/MX339973B/es active IP Right Grant
- 2011-11-15 AU AU2011329076A patent/AU2011329076B2/en not_active Ceased
- 2011-11-15 JP JP2013539938A patent/JP5877847B2/ja active Active
- 2011-11-15 EP EP11791692.4A patent/EP2640697B1/en active Active
- 2011-11-15 NZ NZ609816A patent/NZ609816A/en not_active IP Right Cessation
- 2011-11-15 KR KR1020137012697A patent/KR20130101094A/ko active IP Right Grant
- 2011-11-15 US US13/296,384 patent/US8629169B2/en active Active
-
2013
- 2013-04-18 IL IL225843A patent/IL225843A/en not_active IP Right Cessation
- 2013-04-22 ZA ZA2013/02918A patent/ZA201302918B/en unknown
- 2013-04-24 CR CR20130178A patent/CR20130178A/es unknown
- 2013-05-08 DO DO2013000099A patent/DOP2013000099A/es unknown
- 2013-05-13 MA MA35898A patent/MA34663B1/fr unknown
- 2013-05-15 GT GT201300126A patent/GT201300126A/es unknown
- 2013-05-15 CL CL2013001345A patent/CL2013001345A1/es unknown
- 2013-05-17 EC ECSP13012629 patent/ECSP13012629A/es unknown
- 2013-05-30 CO CO13133036A patent/CO6761385A2/es unknown
-
2017
- 2017-10-27 HR HRP20171649TT patent/HRP20171649T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201500138A (es) | Novedososo derivados de bencimidazol como antagonistas de ep4 | |
| DOP2012000135A (es) | Compuestos de espiropiperidina como antagonistas del receptor orl-1 | |
| CR20150370A (es) | Compuestos antivirales | |
| UY35257A (es) | Picolinamidas macrocíclicas como fungicidas, composiciones y metodos para el control de enfermedades vegetales | |
| UY33735A (es) | Compuestos antivirales | |
| CR20150271A (es) | Peptidos como agonistas de oxitocina | |
| EP2721011A4 (en) | EP2 RECEPTOR ANTAGONISTS OF PROSTAGLANDINS, DERIVATIVES, COMPOSITIONS AND USES THEREOF | |
| CR20140435A (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| CR20150267A (es) | 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il] 1h-pirazol-3-il}-etil)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8 | |
| CO6761385A2 (es) | Compuestos 3-fenilsulfanilmetil-biciclo[3.1.0]hexano 4-sustituidos como antagonistas de mglur 2/3 | |
| CL2015000038A1 (es) | Métodos para preparar triazolopiridinas sustituidas y compuestos intermediarios. | |
| GT201200328A (es) | Intermedios de agomelatina y método de preparación de éstos | |
| CR20140531A (es) | Derivados de ariletinilo | |
| MX2013005623A (es) | Compuestos de 3-benciloxi-biciclico [3.1.0] hexano 4-sustituidos como antagonistas de mglur 2/3. | |
| UY33409A (es) | Moduladores no competitivos de receptores nicotinicos | |
| CR20150028A (es) | Derivados de ariletinilo | |
| CU20150015A7 (es) | Tris-(hetero)aril-pirazoles y su uso | |
| MX2015005312A (es) | Derivados de 1h-indazol-3-carboxamida y uso de los mismos como antagonistas de p2y12. | |
| CR20140130A (es) | 2-(croman-6-iloxi)-tiazoles sustituidos y su uso como productos farmacéuticos | |
| UY34489A (es) | Derivados del ácido cicloalcanocarboxílico como antagonistas del receptor CXCR3 | |
| TN2013000209A1 (en) | 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists | |
| ES2421810R1 (es) | Intermedios utiles para la sintesis de fexofenadina, procedimientos para su preparacion y para la preparacion de fexofenadina | |
| UA54879U (ru) | Применение антагониста рецепторов интерлейкина-1 как средства антиоксидантного действия | |
| UY34819A (es) | Derivados de ß-aminoácido sustituidos como antagonistas del receptor CXCR3. | |
| CR20140122A (es) | Derivados de anilina, su prepración y su apliación terapéutica |